KBC Group’s Enzo Biochem, Inc. ENZ Stock Holding History

KBC Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-46,734	Closed	-$168K	–	1555
2019 Q3	$168K	Buy	46,734 +29,686	+174%	+$105K	﹤0.01%	1276
2019 Q2	$57K	Buy	17,048 +9,598	+129%	+$33.8K	﹤0.01%	1347
2019 Q1	$20K	Hold	7,450	–	–	﹤0.01%	1376
2018 Q4	$21K	Hold	7,450	–	–	﹤0.01%	1272
2018 Q3	$31K	Hold	7,450	–	–	﹤0.01%	1356
2018 Q2	$39K	Hold	7,450	–	–	﹤0.01%	1238
2018 Q1	$41K	Sell	7,450 -20,861	-74%	-$147K	﹤0.01%	1232
2017 Q4	$231K	Hold	28,311	–	–	﹤0.01%	1114
2017 Q3	$296K	Hold	28,311	–	–	﹤0.01%	1075
2017 Q2	$313K	Hold	28,311	–	–	﹤0.01%	1045
2017 Q1	$237K	Hold	28,311	–	–	﹤0.01%	1169
2016 Q4	$196K	Sell	28,311 -8,374	-23%	-$53.4K	﹤0.01%	1196
2016 Q3	$187K	Buy	36,685 +16,134	+79%	+$96.4K	﹤0.01%	1155
2016 Q2	$123K	Buy	20,551 +13,875	+208%	+$77K	﹤0.01%	1142
2016 Q1	$30K	Buy	+6,676	New	+$29.7K	﹤0.01%	1216

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

KBC Group's ENZ Position: Q4 2019 in Review

KBC Group sold out of Enzo Biochem, Inc. (ENZ) in Q4 2019, closing a stake of 46,734 shares — an estimated $168K sold.

KBC Group first reported a position in ENZ in Q1 2016 and held it in 15 quarters. The position peaked at $313K in Q2 2017. 81 funds tracked by Wall St. Rank hold ENZ as of Q4 2019.

KBC Group reported no remaining Enzo Biochem, Inc. position as of Q4 2019 after selling out during the quarter.
KBC Group sold 46,734 Enzo Biochem, Inc. shares in Q4 2019, an estimated $168K.
KBC Group first reported a position in Enzo Biochem, Inc. in Q1 2016 and held it in 15 quarters.
KBC Group's Enzo Biochem, Inc. position peaked at $313K in Q2 2017.
81 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2019.

Based on KBC Group's 13F filing for Q4 2019, filed 11 Feb 2020.